DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Recall

Ongoing
Drugs
Class I — Dangerous

Recall Date

Jun 17, 2026

Company

SUN PHARMACEUTICAL INDUSTRIES INC

Source

FDA

Units

675 vials

Reason: Presence of Particulate matter: Particulate matter identified as glass.

Class I: Use of the product could cause serious health problems or death.

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

Presence of Particulate matter: Particulate matter identified as glass.

Reason for Recall

Presence of Particulate matter: Particulate matter identified as glass.

Product: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical
Official Recall ID: FDA-DRUG-D-0580-2026
Units affected: 675 vials

What Should I Do?

Check your lot number. Don't stop taking a prescribed medication without talking to your pharmacist or doctor. Contact the pharmacy where you got it about a replacement.

Quantity: 675 vials

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated June 23, 2026

More recalls from SUN PHARMACEUTICAL INDUSTRIES INC

Similar recalls

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.